Paul J Catalano

15PUBLICATIONS
128CO-AUTHORS
Predictive and prognostic markersHaematological tumoursRadiation therapyMolecular targetsVeterinary anaesthesiology and intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 21, 2026
Ultrasensitive circulating tumor DNA analysis improves detection of molecular residual disease in locally advanced esophageal cancer.

|Feb 13, 2026
Characterization of Clinical Outcomes for Patients with Relapsed High-Risk Neuroblastoma After Autologous Stem Cell Transplant and External Beam Radiotherapy.

Mathew Lin, Jie Jane Chen, Rochelle Bagatell

|Jul 11, 2025
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial.

Ayal A Aizer, Shyam K Tanguturi, Diana D Shi

|May 09, 2025
Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab.

Christopher J Graser, Thomas O McDonald, Paul J Catalano

|Mar 26, 2025
Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma.

Ellery Koelker-Wolfe, Karen J Marcus, Steven G DuBois

|May 03, 2024
Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes.

Wenxin Xu, Valerie Gaborieau, Samuel M Niman

Pageof 3

Frequent Collaborators

3 joint publications

Opeyemi A Jegede

3 joint publications

David F McDermott

3 joint publications

Michael B Atkins

3 joint publications

Toni K Choueiri